The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma
Andreas Rosenwald(National Cancer Institute), George W. Wright(National Cancer Institute), Adrian Wiestner(National Cancer Institute), Wing C. Chan(National Cancer Institute), Joseph M. Connors(National Cancer Institute), Elı́as Campo(National Cancer Institute), Randy D. Gascoyne(National Cancer Institute), Thomas M. Grogan(University of Arizona), H. K. Müller-Hermelink(University of Würzburg), Erlend B. Smeland(Norwegian Cancer Society), Michael Chiorazzi(National Cancer Institute), Jena M. Giltnane(National Cancer Institute), Elaine M. Hurt(National Cancer Institute), Hong Zhao(National Cancer Institute), Lauren Averett(National Cancer Institute), Sarah E. Henrickson(National Cancer Institute), Liming Yang(National Cancer Institute), John Powell(National Cancer Institute), Wyndham H. Wilson(National Cancer Institute), Elaine S. Jaffe(National Cancer Institute), Richard Simon(National Cancer Institute), Richard D. Klausner(National Cancer Institute), Emilio Montserrat(National Cancer Institute), Francesc Bosch(National Cancer Institute), Timothy C. Greiner(National Cancer Institute), Dennis D. Weisenburger(National Cancer Institute), Warren G. Sanger(National Cancer Institute), Bhavana J. Davé(National Cancer Institute), James C. Lynch(National Cancer Institute), Julie M. Vose(National Cancer Institute), Jamés O. Armitage(National Cancer Institute), Richard I. Fisher(National Cancer Institute), Thomas P. Miller(University of Arizona), Michael LeBlanc(Fred Hutch Cancer Center), German Ott(University of Würzburg), Stein Kvaløy(Norwegian Cancer Society), Harald Holte(Norwegian Cancer Society), Jan Delabie(Norwegian Cancer Society), Louis M. Staudt(National Cancer Institute)
Cited by 926Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis